Vaccine manufacturing services for infectious diseases

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N98026D00089
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 1% complete
IDV ceiling
$48,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition · 30 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases awarded a multiple-award Indefinite Delivery Contract to Fisher Bioservices Inc. Clinical Trials Division on September 25, 2026, with a ceiling of $48 million and ultimate completion date of September 24, 2036.

This is an open (no set-aside) multiple-award contract. Place of performance is not specified in the source.

The originating solicitation, posted November 24, 2023, sought multiple IDIQs to support development of vaccine and biologic candidates as medical countermeasures against infectious diseases. Services include product development plans, product construction and development, manufacture of clinical and non-clinical materials, and regulatory support. Awards were restricted to small businesses capable of performing work in compliance with cGMP and applicable regulations. The primary NAICS code is 325414; the PSC code is R425. Task order values range from $250,000 to over $5 million, with a seven-year ordering period and ten-year extension for certain task areas.

The contract carries a performance period with base and option years extending through September 2036. No recent task-order activity under this IDIQ is detailed in the source. The solicitation anticipated an original start date of May 1, 2025; the September 2026 award date reflects a delay from the original timeline. Prior contract holders whose agreements were anticipated to expire include Advanced Bioscience Laboratories, International AIDS Vaccine Initiative, and IDT Biologics.

Quick answers

Who was awarded contract 75N98026D00089?

75N98026D00089 was awarded to Fisher Bioservices Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 25, 2026.

How much is contract 75N98026D00089 worth?

75N98026D00089's own ceiling is $48,000,000.

Which agency awarded contract 75N98026D00089?

Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026D00089, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).

Who can order from contract 75N98026D00089?

75N98026D00089 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N98026D00089 competed?

The extent of competition for 75N98026D00089 was full and open competition. The government received 30 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV